In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

We recently compiled a list of the Billionaire Prem Watsa’s Top 15 Long-Term Stock Picks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against Prem Watsa’s other ...

In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales ...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But if ...

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...

Pfizer Inc. closed 17.53% short of its 52-week high of $31.54, which the company reached on July 30th.

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable ...

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the case? These companies make drugs doctors and patients rely on -- and that means no matter what the economy is ...

Merit Financial Group LLC grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 60.8% during the fourth quarter, ...